Abera Bioscience AB
Cristina Glad is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. As the CEO and Founder of C Glad Consulting AB since December 2012, Cristina has also served on the boards of various companies, including Abera Bioscience AB, Aptahem, and Laccure AB, where Cristina holds the position of Chairman of the Board. Previous board involvement includes RhoVac, Region Skåne Holding AB, and Guard Therapeutics, among others. Cristina's educational background includes a D.Sc. in Biochemistry and a MSc in Chemical Engineering from Lund University, complemented by an E*MBA from the Scandinavian International Management Institute in Copenhagen.
This person is not in the org chart
This person is not in any teams
Abera Bioscience AB
Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide. Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.